Sanofi-Aventis is to buy TargeGen, a US biopharmaceutical company which develops small molecule kinase inhibitors. The drugs are used to …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

